Detection method for detecting H1N1 influenza virus

Through the complementary pairing of MB-Au-Apt1 and AuPtNFs-Apt2 sandwich structure and AuPtNFs-Probe, the dual amplification of the detection signal of H1N1 influenza virus is achieved, solving the problems of few detection sites and low sensitivity, and achieving rapid and high Sensitivity detection effect.

CN118980813AActive Publication Date: 2024-11-19HEFEI UNIV OF TECH

Patent Information

Application Number
CN202410908251.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-08
Publication Date
2024-11-19
Estimated Expiration
2044-07-08

AI Technical Summary

Technical Problem

The existing H1N1 influenza virus detection methods have the problems of few detection sites and low sensitivity, and cannot meet the fast, sensitive and portable diagnostic needs.

Method used

MB-Au-Apt1 and AuPtNFs-Apt2 are used to form a sandwich structure, and AuPtNFs-Probe is added through base complementary pairing to achieve dual amplification of HA detection signals and improve detection sites and sensitivity.

Benefits of technology

Through the dual signal amplification strategy, fast and sensitive detection of low-concentration HA is achieved, the detection limit is reduced, the detection sensitivity is improved, and the detection can be completed within ten minutes, with good selectivity and high sensitivity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118980813A_ABST
    Figure CN118980813A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of electrochemical analysis, in particular to a detection method for detecting H1N1 influenza virus. The detection method for detecting the H1N1 influenza virus comprises the following steps: adding a to-be-detected sample HA into an MB-Au-Apt1 dispersion liquid to obtain a mixed liquid I; and suspending the solid in the mixed solution I in a PBS buffer solution. Then an AuPtNFs-Apt2 dispersion liquid is added, and a second mixed solution is obtained; and resuspending the solid in the mixed solution II in a 1 / 4 SSC buffer solution. And then an AuPtNFs-Probe dispersion liquid is added, and a third mixed solution is obtained. And resuspending the solid in the mixed solution III in the PBS buffer solution to obtain the sample treatment solution. And detecting the HA in the sample treatment liquid on an electrochemical platform through differential pulse voltammetry to obtain the concentration of the HA in the sample to be detected. According to the invention, the amplification of a detection signal is realized through the catalytic property of AuPtNFs, the amplification of the number of AuPt nanoflowers and the re-amplification of the detection signal are realized by utilizing the attribute that an aptamer is nucleic acid and the principle that a base is complementary ligand, and finally the sensitive detection of HA protein in the H1N1 influenza virus is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of electrochemical analysis, in particular to a detection method for detecting H1N1 influenza virus. Background Art

[0002] Influenza viruses co-circulate around the world, causing epidemics every year with significant negative impacts on public health and the global economy. Since 2010, seasonal influenza cases have increased dramatically from 9 million to 45 million, with 65,000 deaths each year. The influenza A virus, known as H1N1, is spread through the air and is highly contagious among people. Hemagglutinin, or HA, is an abundant and tiny membrane protein (Stokes radius: 8.5 nm) that confers H1N1 its ability to infect. Therefore, in order to reduce the impact of influenza viruses, it is crucial to have access to rapid, sensitive, and portable diagnostic methods.

[0003] The identification of influenza viruses uses conventional virus diagnostic techniques, including virus culture, polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA). Among them, virus culture requires well-trained laboratory personnel, sterile laboratory benches, and longer culture times. Although polymerase chain reaction is a commonly used virus detection technology, it is labor-intensive and requires large instruments. For ELISA technology, it mainly relies on antibodies to capture viruses for detection, which is mainly limited by sensitivity and specificity.

[0004] Although the above detection methods can all detect influenza viruses, these methods either require contact with live viruses, or are complicated to operate, time-consuming and labor-intensive, or have few detection sites and low sensitivity, making the above detection methods unable to meet actual detection needs. Summary of the invention

[0005] In order to solve the problem of few detection sites and low sensitivity when detecting H1N1 influenza virus in the prior art, the present invention provides a detection method for detecting H1N1 influenza virus, which can double amplify the detection signal, increase the detection sites, and improve the detection speed and sensitivity.

[0006] To achieve the above purpose, the technical solution adopted by the present invention is: a detection method for detecting H1N1 influenza virus, characterized in that it comprises the following steps:

[0007] Treating the sample HA to be tested: adding the sample HA to be tested to the MB-Au-Apt1 dispersion and mixing them completely to obtain a mixed solution one; then separating the solid in the mixed solution one by an external magnetic field, and resuspending the separated solid in a PBS buffer; then adding the AuPtNFs-Apt2 dispersion to the PBS buffer to mix, to obtain a mixed solution two; separating the solid in the mixed solution two by an external magnetic field to obtain MB-Au-Apt1@HA@AuPtNFs-Apt2, and resuspending it in 1 / 4 SSC buffer; then adding the AuPtNFs-Probe dispersion to the 1 / 4 SSC buffer to mix, to obtain a mixed solution three, separating the solid in the mixed solution three by an external magnetic field, and resuspending the separated solid in a PBS buffer to obtain a sample treatment solution;

[0008] The prepared sample treatment solution is added dropwise onto the electrode of the electrochemical platform for detecting HA, and then the electrode is immersed in a PBS buffer containing HQ and H2O2 for a period of time;

[0009] Then, DPV potential scanning was performed from −0.1 V to 0.6 V at a pulse amplitude of 50 mV, a pulse period of 500 ms, and a quiet time of 2 s;

[0010] The electrochemical platform can obtain the concentration of HA of the sample to be detected through the result of potential scanning.

[0011] As a further improvement of the above scheme, during the treatment of the sample HA to be detected, the nucleic acid aptamer Apt1 in the MB-Au-Apt1 dispersion is used to capture HA and form a sandwich structure MB-Au-Apt1@HA@AuPtNFs-Apt2 with the nucleic acid aptamer Apt2 in the AuPtNFs-Apt2 dispersion.

[0012] As a further improvement of the above scheme, the AuPtNFs-Probe in the AuPtNFs-Probe dispersion is connected to the AuPtNFs-Apt2 on the MB-Au-Apt1@HA@AuPtNFs-Apt2 by base complementary pairing to form MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe with multiple AuPtNFs-Probes.

[0013] As a further improvement of the above solution, before processing the sample HA to be detected, a nanocomposite material needs to be prepared, and the nanocomposite material includes a MB-Au dispersion and an AuPtNFs dispersion.

[0014] As a further improvement of the above scheme, the preparation method of the MB-Au dispersion comprises the following steps:

[0015] preparing Fe3O4 dispersion;

[0016] The prepared Fe3O4 dispersion is dispersed in a mixture of ethanol and water, and ultrasonically dispersed, 25% ammonia water is added after ultrasonication, and tetraethyl orthosilicate is added dropwise, and then stirred at room temperature to obtain a suspension 1;

[0017] The suspension is separated by a magnet, and washed with ethanol and deionized water for multiple times to obtain Fe3O4@SiO2;

[0018] The prepared Fe3O4@SiO2 was dispersed in a mixture of ethanol and deionized water, and subjected to ultrasound. After ultrasound, 3-aminopropyltriethoxysilane was added dropwise, and stirred at room temperature for a period of time under nitrogen protection to obtain a second suspension.

[0019] The suspension 2 is separated by a magnet, and washed with ethanol and deionized water for multiple times to obtain Fe3O4@SiO2-NH2, which is dispersed in 50 mL of deionized water to obtain MB dispersion;

[0020] A certain amount of the MB dispersion is taken and subjected to ultrasonic treatment, and then HAuCl4 aqueous solution and sodium citrate aqueous solution are added respectively, and stirred, and after stirring for a period of time, sodium borohydride is added to react to obtain suspension three;

[0021] The suspension three was separated by a magnet, and washed with ethanol and deionized water for multiple times to obtain MB-Au, which was then dispersed in 50 mL of deionized water to obtain the MB-Au dispersion.

[0022] As a further improvement of the above scheme, the method for preparing the AuPtNFs dispersion comprises the following steps:

[0023] Adding the HAuCl4 solution into a container containing water to obtain a mixed solution 4, and heating the mixed solution 4 to boiling;

[0024] Rapidly add sodium citrate solution to the boiling mixture 4 and boil while stirring.

[0025] After boiling for a period of time, ascorbic acid and H2PtCl6 were added respectively, and heating was continued for 20 minutes to obtain the AuPtNFs dispersion.

[0026] As a further improvement of the above scheme, the preparation method of the MB-Au-Apt1 dispersion comprises the following steps:

[0027] Taking a certain amount of the prepared MB-Au dispersion, adding the nucleic acid aptamer Apt1 to the MB-Au dispersion, and incubating at 25° C. for 2 hours to obtain a suspension IV;

[0028] The supernatant of the suspension 4 is removed by a magnet to obtain a precipitate 1; the precipitate 1 is then washed with PBS buffer for three times;

[0029] The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA, and shaken at 25° C. for 0.5 h to obtain a suspension solution 5;

[0030] The suspension was separated by a magnet to obtain MB-Au-Apt1, and the MB-Au-Apt1 was resuspended in 200 μL of PBS solution to obtain the MB-Au-Apt1 dispersion.

[0031] As a further improvement of the above scheme, the preparation of AuPtNFs-Apt2 further includes the following steps:

[0032] Taking a certain amount of the prepared AuPtNFs dispersion, adding the nucleic acid aptamer Apt2 to the AuPtNFs dispersion, and incubating at 25° C. for 2 h to obtain a suspension VI;

[0033] The supernatant of the mixed solution 6 is removed by a magnet to obtain a precipitate 2; the precipitate 2 is then washed with a PBS buffer solution for three times;

[0034] The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA, and shaken at 25° C. for 0.5 h to obtain a suspension 7;

[0035] The suspension was separated by a magnet to obtain AuPtNFs-Apt2, which was then resuspended in 200 μL PBS solution to obtain the AuPtNFs-Apt2 dispersion.

[0036] As a further improvement of the above scheme, the preparation of the AuPtNFs-Probe dispersion further includes the following steps:

[0037] Taking a certain amount of the prepared AuPtNFs dispersion, adding the DNA probe Probe to the AuPtNFs dispersion, and incubating at 25° C. for 2 hours to obtain a suspension eight;

[0038] The supernatant of the suspension solution 8 is removed by a magnet to obtain a precipitate 3; and the precipitate 3 is washed with a PBS buffer solution;

[0039] The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA, and shaken at 25° C. for 0.5 h to obtain suspension nine;

[0040] The suspension was separated by a magnet to obtain AuPtNFs-Probe, which was then resuspended in 200 μL of PBS solution to obtain the AuPtNFs-Probe dispersion.

[0041] As a further improvement of the above scheme, the DNA nucleotide sequence of the nucleic acid aptamer Apt1 is 5'-HS-(CH2)6-TACTGCACACGACACCGACTGTCACCATCACCTCGGCGCA-3'.

[0042] As a further improvement of the above scheme, the DNA nucleotide sequence of the nucleic acid aptamer Apt2 is 5'-HS-(CH2)6-GGCCTACCGTAGTGTGCGTGGGCACATGTTCGCGCCACCGTGCTACAAC-3'.

[0043] Furthermore, the nucleotide sequence of the DNA probe Probe is 5'-HS-(CH2)6-GTTGTAGCACG-3'.

[0044] Compared with the prior art, the present invention has the following beneficial effects:

[0045] (1) In the present invention, the nucleic acid aptamer Apt1 in the MB-Au-Apt1 dispersion is used to capture HA and form a sandwich structure MB-Au-Apt1@HA@AuPtNFs-Apt2 with the nucleic acid aptamer Apt2 in the AuPtNFs-Apt2 dispersion. The sandwich structure material is dripped onto the electrode, and the detection signal of HA can be amplified in the HQ / H2O2 and PBS buffer systems using differential pulse voltammetry. At the same time, the AuPtNFs-Probe in the AuPtNFs-Probe dispersion can also connect to the AuPtNFs-Apt2 on the MB-Au-Apt1@HA@AuPtNFs-Apt2 by base complementary pairing, so as to form MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe with multiple AuPtNFs-Probes, thereby increasing the detection sites in the HA detection process, thereby realizing the re-amplification of the HA detection signal. Through this dual signal amplification strategy, rapid and sensitive detection of HA can be achieved, and its detection effect can be improved.

[0046] (2) The present invention can detect low-concentration HA through a dual signal amplification strategy for HA detection signals, thereby further improving the sensitivity of the HA detection process.

[0047] (3) The present invention can effectively reduce the detection limit in the HA detection process by performing a double signal amplification strategy on the HA detection signal, and the lower the detection limit, the higher the detection sensitivity of the method. By analyzing the detection limit, it can be seen that the detection limit of the HA detection signal after secondary amplification is reduced by about 8 times compared with the detection limit of the HA detection signal after single amplification, which shows that secondary amplification of the HA detection signal can achieve further sensitive detection of HA. BRIEF DESCRIPTION OF THE DRAWINGS

[0048] Figure 1 This is a schematic diagram of processing the sample HA to be detected in Example 1 of the present invention.

[0049] Figure 2 This is a flow chart of the preparation of the MB-Au-Apt1 dispersion and the AuPtNFs-Apt2 dispersion in Example 1 of the present invention.

[0050] Figure 3 This is a DPV signal diagram of HA of the present invention under different treatment methods on an electrochemical platform.

[0051] Figure 4 Transmission electron microscope (TEM) images of different products of the MB-Au dispersion of the present invention during the preparation stage.

[0052] Figure 5 Transmission electron microscope (TEM) images of different products of the AuPtNFs dispersion in the preparation stage of the present invention.

[0053] Figure 6 This is a DPV signal graph of a series of HA with known concentrations in Experiment 1 of the present invention.

[0054] Figure 7 It is a standard curve diagram between HA concentration and current in Experiment 1 of the present invention.

[0055] Figure 8 This is a DPV signal diagram of a series of HA with known concentrations in Experiment 2 of the present invention.

[0056] Fig. 9 It is a standard curve diagram between HA concentration and current in Experiment 2 of the present invention.

[0057] Fig.10 These are two groups of DPV signal graphs obtained under the conditions of Experiment 1 and Experiment 2 when the HA concentration in the present invention is 50 pg / mL.

[0058] Description of sequence listing (Sequence listing content is provided separately)

[0059] SEQ ID NO.1 is the DNA nucleotide sequence of the nucleic acid aptamer Apt1 described in the embodiment of the present invention;

[0060] SEQ ID NO.2 is the DNA nucleotide sequence of the nucleic acid aptamer Apt2 described in the embodiment of the present invention;

[0061] SEQ ID NO.3 is the nucleotide sequence of the DNA probe Probe described in the examples of the present invention. DETAILED DESCRIPTION

[0062] The present invention is further described below in conjunction with specific implementation methods. It should be noted that, under the premise of no conflict, the various embodiments or technical features described below can be arbitrarily combined to form a new embodiment.

[0063] In the description of the present invention, it should be noted that for directional words, such as the terms "center", "lateral", "longitudinal", "length", "width", "thickness", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", "clockwise", "counterclockwise" and the like indicating directions and positional relationships are based on the directions or positional relationships shown in the drawings, which are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and cannot be understood as limiting the specific protection scope of the present invention. The terms "first", "second", etc. in the specification and claims of the present invention are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. The terms "including" and "having" in the specification and claims of the present invention and any variations thereof are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device including a series of steps or units is not necessarily limited to those steps or units clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.

[0064] Example 1

[0065] Reference Figure 1 As shown, an embodiment of the present invention provides a detection method for detecting H1N1 influenza virus, which includes the following steps:

[0066] (1) Treating the sample HA to be tested: Add the sample HA to be tested to the MB-Au-Apt1 dispersion and mix thoroughly to obtain a mixed solution 1. Then separate the solids in the mixed solution 1 by an external magnetic field, and resuspend the separated solids in PBS buffer. Add AuPtNFs-Apt2 dispersion to the PBS buffer and mix to obtain a mixed solution 2. Separate the solids in the mixed solution 2 by an external magnetic field to obtain MB-Au-Apt1@HA@AuPtNFs-Apt2, and resuspend it in 1 / 4SSC buffer. Add AuPtNFs-Probe dispersion to 1 / 4SSC buffer and mix to obtain a mixed solution 3. Separate the solids in the mixed solution 3 by an external magnetic field, and resuspend the separated solids in PBS buffer to obtain a sample treatment solution.

[0067] (2) adding the prepared sample treatment solution dropwise onto the electrode of the electrochemical platform for detecting HA, and then immersing the electrode in a PBS buffer containing HQ and H2O2 for a period of time;

[0068] (3) Then, a DPV potential scan was performed from -0.1 V to 0.6 V at a pulse amplitude of 50 mV, a pulse period of 500 ms, and a quiet time of 2 s;

[0069] (4) The electrochemical platform can obtain the concentration of HA in the sample to be tested through the results of potential scanning.

[0070] 1 / 4SSC means the SSC concentration is diluted four times.

[0071] In this embodiment, SSC is 20X SSC buffer, whose components are 3 mol / L NaCl, 300 mmol / L sodium citrate, and pH is 6.9-7.1.

[0072] In this embodiment, the external magnetic field can be achieved by a magnet.

[0073] In this embodiment, the electrochemical platform may be an electrochemical biosensor, which has good anti-interference, stability and repeatability.

[0074] It is understood that in the present invention, in order to capture HA and achieve magnetic separation, Au nanoparticles are encapsulated on magnetic beads and then connected to the nucleic acid aptamer Apt1 through an Au-S bond. In addition, the present invention also prepares AuPt nanoflowers (i.e., AuPtNFs) with catalase properties, which can be connected to the nucleic acid aptamer Apt2 through a Pt-S bond and form a sandwich structure with magnetic beads and HA. The presence of AuPtNFs, H2O2 and hydroquinone (HQ) causes the oxide of HQ to produce an amplified DPV signal. In addition, Apt2 can both capture the target and connect to the single-stranded DNA probe through base complementary pairing, so that the number of AuPtNFs on the sandwich structure is increased, and the detection signal is amplified again. More importantly, the entire detection can be completed within ten minutes, with good selectivity and high sensitivity. This electrochemical aptamer sensor shows the potential as a reliable diagnostic tool for influenza virus and can effectively control the spread of influenza.

[0075] In this embodiment, HA is subjected to a series of treatments in step (1) before the concentration of HA is detected. Through this series of treatments, the detection sites in the detection process can be increased, and the detection signal can also be double amplified to improve the sensitivity of the detection.

[0076] Specifically, in this embodiment, HA is captured by the nucleic acid aptamer Apt1 in the MB-Au-Apt1 dispersion and forms a sandwich structure MB-Au-Apt1@HA@AuPtNFs-Apt2 with the nucleic acid aptamer Apt2 in the AuPtNFs-Apt2 dispersion. The material of this sandwich structure is dripped onto the electrode, and the detection signal of HA can be amplified in the HQ / H2O2 and PBS buffer systems using differential pulse voltammetry. In addition, in this embodiment, the base complementary pairing principle of the nucleic acid aptamer Apt2 and the DNA probe Probe can be used to amplify AuPtNFs, so as to increase the detection sites in the HA detection process, thereby realizing the re-amplification of the HA detection signal. Therefore, the present invention can realize double amplification of the detection signal when detecting HA by performing the above-mentioned treatment on the sample HA to be detected, thereby greatly improving its detection sensitivity.

[0077] Please refer to Figure 1, wherein, in the process of treating the sample HA to be detected, the nucleic acid aptamer Apt1 in the MB-Au-Apt1 dispersion is used to capture HA and form a sandwich structure MB-Au-Apt1@HA@AuPtNFs-Apt2 with the nucleic acid aptamer Apt2 in the AuPtNFs-Apt2 dispersion. This sandwich structure material is dripped onto the electrode, and the detection signal of HA can be amplified in the HQ / H2O2 and PBS buffer system using differential pulse voltammetry. In this embodiment, by using nucleic acid aptamers to replace traditional antibodies, it can specifically bind to HA, thereby improving the sensitivity of the HA detection process.

[0078] In this embodiment, the AuPtNFs-Probe in the AuPtNFs-Probe dispersion can also connect to the AuPtNFs-Apt2 on the MB-Au-Apt1@HA@AuPtNFs-Apt2 by base complementary pairing, so as to form MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe with multiple AuPtNFs-Probes, thereby increasing the detection sites in the HA detection process, thereby realizing the re-amplification of the HA detection signal. By re-amplifying the detection signal, sensitive detection of the HA protein in the H1N1 influenza virus can be achieved.

[0079] Please refer to Figure 1 , Figure 1 This is a schematic diagram of processing the sample HA to be tested in this embodiment. Figure 1 It can be seen that by performing the above-mentioned treatment on the sample HA to be detected, it is possible to increase the detection sites of HA during detection, realize double amplification of the HA detection signal, and improve the detection sensitivity of HA.

[0080] Figure 3 (a) is a schematic diagram of a structure for amplifying the HA detection signal once; Figure 3 (b) is a schematic diagram of the structure for secondary amplification of the detection signal of HA; Figure 3 (c) is a curve diagram of voltage and current during the electrochemical platform detection when the HA detection signal is amplified once, the HA signal is amplified twice, and there is no HA.

[0081] Specific: Figure 3Part (a) is MB-Au-Apt1@HA@AuPtNFs-Apt2, which is used to capture HA only through aptamer Apt1 and forms a sandwich structure with aptamer Apt2 in the AuPtNFs-Apt2 dispersion. This sandwich structure material is dropped onto the electrode, and the detection signal of HA can be amplified in the HQ / H2O2 and PBS buffer systems using differential pulse voltammetry.

[0082] Figure 3 Part (b) is a MB-Au-Apt1@HA@AuPtNFs-Apt2 in which nucleic acid aptamer Apt1 is used to capture HA and forms a sandwich structure with nucleic acid aptamer Apt2 in the AuPtNFs-Apt2 dispersion to amplify the detection signal of HA once; and AuPtNFs-Probe in the AuPtNFs-Probe dispersion can also connect to AuPtNFs-Apt2 on MB-Au-Apt1@HA@AuPtNFs-Apt2 by base complementary pairing to form MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe with multiple AuPtNFs-Probes, thereby achieving a secondary amplification of the detection signal of HA.

[0083] pass Figure 3 As can be seen from the curve diagram in part (c), when there is no HA, there is no electrical signal. The current peak of the DPV detection signal of HA after the secondary amplification of HA is significantly greater than the current peak of the DPV detection signal of HA after the primary amplification of HA, which indicates that the DNA probe Probe in this embodiment can achieve the amplification of AuPtNFs through base complementary pairing, thereby increasing the detection signal.

[0084] Wherein, before treating the sample HA to be detected, a nanocomposite material needs to be prepared, and the nanocomposite material includes MB-Au dispersion and AuPtNFs dispersion.

[0085] In this embodiment, the preparation method of MB-Au dispersion includes the following steps:

[0086] (31) Take 5 mL of the prepared Fe3O4 dispersion and disperse it in 40 mL of ethanol and 10 mL of water, and then ultrasonically disperse it for 20 min. After ultrasonication, add 1 mL of 25% ammonia water under mechanical stirring, and then add 1.2 mL of tetraethyl orthosilicate dropwise, and then stir at room temperature for 8 h to obtain suspension 1.

[0087] (32) The suspension 1 was separated by a magnet and washed three times with ethanol and deionized water, respectively, to obtain Fe 3 O 4 @SiO 2 .

[0088] (33) The prepared Fe3O4@SiO2 was dispersed in 48 mL of ethanol and 2 mL of deionized water and ultrasonically dispersed for 20 min. After ultrasonication, 200 mg of 3-aminopropyltriethoxysilane was added dropwise and stirred at room temperature for 4 h under nitrogen protection to obtain suspension 2.

[0089] (34) The suspension II was separated by a magnet and washed three times with ethanol and deionized water, respectively, to obtain Fe 3 O 4 @SiO 2 -NH 2 , which was then dispersed in 50 mL of deionized water to obtain MB dispersion.

[0090] (35) Take 5 mL of MB dispersion and treat it ultrasonically for 20 min. Then, add 10 mL of HAuCl4 aqueous solution with a mass concentration of 1 mg / mL and 10 mL of sodium citrate aqueous solution with a mass concentration of 2 mg / mL to the MB dispersion after ultrasonication. Stir the mixture for 10 min. After stirring, add 6 mL of sodium borohydride with a mass concentration of 0.144 mg / mL to react to obtain suspension 3.

[0091] (36) After 1 h of reaction, the suspension was separated by a magnet and washed three times with ethanol and deionized water to obtain MB-Au, which was then dispersed in 50 mL of deionized water to obtain MB-Au dispersion.

[0092] The preparation steps of the Fe3O4 dispersion in step (31) are as follows: 1.35 g of FeCl3·6H2O, 0.22 g of trisodium citrate, and 4.92 g of sodium acetate are dissolved in 40 mL of ethylene glycol, and stirred by magnetic force for 30 min to form a uniform solution. The above-mentioned solution after the reaction is completely placed in a polytetrafluoroethylene liner, and sealed in a high-pressure reactor, reacted at 180° C. for 11 h, and after the reactor is cooled to room temperature, the material is recovered by a magnet, and the recovered material is washed with anhydrous ethanol and deionized water in turn to obtain Fe3O4 nanoparticles. Finally, the Fe3O4 nanoparticles are dispersed in 20 mL of deionized water to obtain a Fe3O4 dispersion.

[0093] Please refer to Figure 4 , Figure 4 Part (A) is the transmission electron microscope (TEM) image of the prepared Fe3O4; Figure 4 Part (B) is the transmission electron microscope (TEM) image of Fe3O4@SiO2 prepared; Figure 4 Part (C) shows the transmission electron microscope (TEM) image of the prepared MB-Au. Figure 4 Part (D) in the middle is a schematic diagram of the prepared MB-Au before and after magnet separation.

[0094] Please refer to Figure 2 In part (d), in this embodiment, the preparation of the MB-Au-Apt1 dispersion comprises the following steps:

[0095] (41) Take 200 μL of the MB-Au dispersion prepared in step (36), and take 20 μL of the aptamer Apt1 with a molar concentration of 10 nM, add the aptamer Apt1 to the MB-Au dispersion, and incubate at 25° C. for 2 hours to obtain a suspension 4. The obtained suspension 4 is an intermediate step of connecting MB-Au and the aptamer Apt1, in which the aptamer Apt1 is in excess.

[0096] (42) The supernatant of the suspension 4 is removed by a magnet to obtain a precipitate 1; the precipitate 1 is then washed three times with a PBS buffer having a pH of 7.2 and a molar concentration of 0.01 M. In this step, the supernatant of the suspension 4 is removed by a magnet mainly to remove excess nucleic acid aptamer Apt1.

[0097] (43) The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA and shaken at 25 °C for 0.5 h to obtain suspension 5.

[0098] (44) The suspension 5 was separated by a magnet to obtain MB-Au-Apt1, which was then resuspended in 200 μL of PBS solution to obtain MB-Au-Apt1 dispersion.

[0099] Wherein, the 2% BSA in step (43) refers to bovine serum albumin with a mass fraction of 2%.

[0100] Wherein, the DNA nucleotide sequence of the nucleic acid aptamer Apt1 in step (41) is 5'-HS-(CH2)6-TACTGCACACGACACCGACTGTCACCATCACCTCGGCGCA-3'.

[0101] In this embodiment, the preparation method of AuPtNFs dispersion includes the following steps:

[0102] (51) The glassware and magnetic stirrer were cleaned with freshly prepared aqua regia and then rinsed with deionized water. A 2 mL HAuCl4 solution with a mass concentration of 10 mg / mL was added to a glassware containing 200 mL of water to obtain a mixed solution 4, which was heated to boiling.

[0103] (52) 3.2 ml of 10 mg / mL sodium citrate solution was quickly added to the boiling mixture, and the mixture was boiled for 10 min.

[0104] (53) Then, 4 mL of ascorbic acid with a mass concentration of 17.6 mg / mL and 5.0 mL of H 2 PtCl 6 with a mass concentration of 10 mg / mL were added to the boiling solution, and heating was continued for 20 min to obtain the AuPtNFs dispersion.

[0105] Please refer to Figure 5 , Figure 5 Part (A) is the transmission electron microscope (TEM) image of Au nanoparticles; Figure 4 Transmission electron microscope (TEM) images of AuPtNFs prepared in parts (B) and (C); Figure 4 The color change diagram of the TMB / H2O2 system with or without the addition of AuPtNFs in the middle (D). The left side of the diagram is without the addition of AuPtNFs, and the right side of the diagram is with the addition of AuPtNFs, because AuPtNFs will turn TMB blue.

[0106] Please refer to Figure 2 In part (e), in this embodiment, the preparation method of AuPtNFs-Apt2 dispersion comprises the following steps:

[0107] (61) Take 200 μL of the AuPtNFs dispersion in step (53), add the prepared aptamer Apt2 to the AuPtNFs dispersion, and incubate at 25° C. for 2 h to obtain a suspension 6. The obtained suspension 6 is an intermediate step of connecting AuPtNFs and aptamer Apt2, in which the aptamer Apt2 is in excess.

[0108] (62) The supernatant of the suspension 6 is removed by a magnet to obtain a precipitate 2, and the precipitate 2 is then washed with a PBS buffer having a pH of 7.2 and a molar concentration of 0.01 M. In this step, the supernatant of the suspension 6 is removed by a magnet mainly to remove excess nucleic acid aptamer 2 Apt2.

[0109] (63) The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA and shaken at 25 °C for 0.5 h to obtain suspension VII.

[0110] (64) The suspension was separated by a magnet to obtain AuPtNFs-Apt2, which was then resuspended in 200 μL of PBS solution to obtain AuPtNFs-Apt2 dispersion.

[0111] Wherein, the DNA nucleotide sequence of the nucleic acid aptamer Apt2 in step (61) is 5'-HS-(CH2)6-GGCCTACCGTAGTGTGCGTGGGCACATGTTCGCGCCACCGTGCTACAAC-3'.

[0112] In this embodiment, the preparation of the AuPtNFs-Probe dispersion further includes the following steps:

[0113] (71) Take 200 μL of the AuPtNFs dispersion in step (53), add the DNA probe Probe to the AuPtNFs dispersion, and incubate at 25° C. for 2 h to obtain a suspension solution VIII.

[0114] (72) The supernatant of suspension 8 is removed by a magnet to obtain precipitate 3; the precipitate 3 is then washed with PBS buffer having a pH of 7.2 and a molar concentration of 0.01 M.

[0115] (73) The washed pellet was resuspended in 200 μL of PBS buffer containing 2% BSA and shaken at 25 °C for 0.5 h to obtain suspension nine.

[0116] (74) The suspension was separated by a magnet to obtain AuPtNFs-Probe, which was then resuspended in 200 μL of PBS solution to obtain AuPtNFs-Probe dispersion.

[0117] Wherein, the nucleotide sequence of the DNA probe Probe in step (71) is 5'-HS-(CH2)6-GTTGTAGCACG-3'.

[0118] Example 2

[0119] Before detecting HA of unknown concentration, it is necessary to first configure multiple groups of HA of different known concentrations, and place these HA of known concentrations in the electrochemical platform for detection to obtain a series of current data. A standard curve of the relationship between the concentration and current in HA can be drawn through this series of current data. After obtaining the standard curve, if it is necessary to detect HA of unknown concentration, it is only necessary to place HA in the electrochemical platform for detection in the manner of Example 1. The electrochemical platform can calculate the concentration of HA of unknown concentration based on the results of DPV potential scanning and the standard curve, thereby achieving the purpose of detecting HA concentration.

[0120] In this example, two sets of experiments were performed to draw standard curves of the relationship between the concentration and current of two different HAs. Experiment 1 was to amplify the detection signal of HA of known concentration by the following method: MB-Au-Apt1 captured HA and formed a sandwich structure with AuPtNFs-Apt2, and differential pulse voltammetry was used to amplify the HA detection signal in the HQ / H2O2 and PBS systems. Experiment 2 was to amplify the detection signal twice for HA of known concentration in the following ways: HA was captured by MB-Au-Apt1 and formed a sandwich structure with AuPtNFs-Apt2, and the HA detection signal was amplified in the HQ / H2O2 and PBS system using differential pulse voltammetry; AuPtNFs-Probe was connected to AuPtNFs-Apt2 on MB-Au-Apt1@HA@AuPtNFs-Apt2 by base complementary pairing to form MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe with multiple AuPtNFs-Probes, thereby amplifying the AuPtNFs formation and amplifying the detection signal again.

[0121] The specific steps of Experiment 1 are as follows:

[0122] (11) Prepare a series of HA with known concentrations.

[0123] (12) Select 15 μL of HA with a known concentration from one of the groups and add it to 100 μL of MB-Au-Apt1 dispersion and mix thoroughly to obtain a mixed solution a.

[0124] (13) The mixed solution a in step (12) is separated by an external magnetic field to obtain a solid a1.

[0125] (14) The solid a1 in step (13) was suspended in 100 μL of PBS buffer, and 15 μL of AuPtNFs-Apt2 was added and mixed to obtain a mixed solution b.

[0126] (15) The mixed solution b in step (14) is separated by an external magnetic field to obtain a solid b1, where the solid b1 is MB-Au-Apt1@HA@AuPtNFs-Apt2, and the solid b1 is resuspended in 10 μL of PBS buffer to obtain a sample treatment solution 1.

[0127] (16) Take 10 μL of the sample treatment solution 1 in step (15) and drip it onto the magnetic glassy carbon electrode of the electrochemical platform, and then immerse the magnetic glassy carbon electrode in a PBS buffer solution containing HQ and H2O2 for 6 min. The pH of the PBS buffer solution is 7.2, the volume molar concentration is 0.01 M, the mass concentration of HQ is 1.0 mg / mL, and the volume molar concentration of H2O2 is 10 mM.

[0128] (17) Then, the DPV potential was scanned from −0.1 V to 0.6 V at a pulse amplitude of 50 mV, a pulse period of 500 ms, and a quiet time of 2 s to obtain the DPV signal graph.

[0129] The above series of HA with known concentrations were tested according to steps (12) to (17) to obtain a series of DPV signal graphs. The specific results are as follows: Figure 6 shown.

[0130] pass Figure 6 The peak current and concentration in the experiment were analyzed, and a standard curve between the concentration and current of HA in experiment 1 was drawn. The standard curve is shown in Figure 7 The standard curve equation is ΔI=k*lgC HA +b. Among them, ΔI is the current increment, C HA is the concentration of HA, k is the slope of the standard curve, and b is a constant.

[0131] The specific steps of Experiment 2 are as follows:

[0132] (21) A series of HA with known concentrations were prepared.

[0133] (22) 15 μL of HA with a known concentration was selected and added to 100 μL of MB-Au-Apt1 dispersion and mixed thoroughly to obtain a mixed solution a.

[0134] (23) The mixed solution a in step (22) is separated by an external magnetic field to obtain a solid a1.

[0135] (24) The solid a1 in step (24) was suspended in 100 μL of PBS buffer, and 15 μL of AuPtNFs-Apt2 was added and mixed to obtain a mixed solution b.

[0136] (25) The mixed solution b in step (14) was separated by an external magnetic field to obtain a solid b1, which was MB-Au-Apt1@HA@AuPtNFs-Apt2. The solid b1 was resuspended in 100 μL of 1 / 4 SSC buffer, and then 20 μL of AuPtNFs-Probe dispersion was added to obtain a mixed solution c.

[0137] (26) The mixed solution c in step (25) is separated by an external magnetic field to obtain solid c1, which is MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe, and the solid c1 is resuspended in 10 μL of PBS buffer to obtain sample treatment solution 2.

[0138] (27) Take 10 μL of the sample treatment solution 2 in step (26) and drip it onto the magnetic glassy carbon electrode of the electrochemical platform, and then immerse the magnetic glassy carbon electrode in a PBS buffer solution containing HQ and H2O2 for 6 min. The pH of the PBS buffer solution is 7.2, the volume molar concentration is 0.01 M, the mass concentration of HQ is 1.0 mg / mL, and the volume molar concentration of H2O2 is 10 mM.

[0139] (28) Then, the DPV potential was scanned from −0.1 V to 0.6 V at a pulse amplitude of 50 mV, a pulse period of 500 ms, and a quiet time of 2 s to obtain the DPV signal graph.

[0140] The above series of HA with known concentrations are tested according to steps (22) to (28) to obtain a series of DPV signal graphs. The specific results are as follows: Figure 8 shown.

[0141] pass Figure 8 The peak current and concentration in the experiment were analyzed, and a standard curve between the concentration and current of HA in experiment 2 was drawn. The standard curve is shown in Fig. 9 The standard curve equation is ΔI=k*lgC HA +b. Among them, ΔI is the current increment, C HA is the concentration of HA, k is the slope of the standard curve, and b is a constant.

[0142] Through Figures 8 to 9 The analysis shows that Figure 8 The standard equation of the standard curve is ΔI = (13.77 ± 0.71) * lgC HA +(30.82±0.98). Figure 8 The standard curve equation is ΔI = (8.55 ± 0.33) * lgC HA +(36.27±0.67).

[0143] The calculation formula of the detection limit (LOD) is LOD = 3σ / k, where σ is the standard deviation of the blank sample and k is the slope of the standard curve. The detection limits in the first and second experiments can be calculated by the above calculation formula.

[0144] The detection limit refers to the minimum concentration or content of an element required to produce an analytical signal that can be reliably detected. Therefore, the lower the detection limit, the higher the sensitivity of the method or instrument.

[0145] Through Figure 6 to Figure 7 The data in the experiment were analyzed and it can be seen that after amplifying the HA detection signal once, the electrochemical platform can sensitively detect HA with a concentration of 10pg / mL to 100ng / mL, and its detection limit is 2.4pg / mL. Figure 8 and Fig. 9 From the data analysis, it can be seen that after the HA detection signal was amplified twice in Experiment 2, the electrochemical platform was able to sensitively detect HA with a concentration of 0.5pg / mL to 10ng / mL, and its detection limit was 0.3pg / mL. From the analysis of the detection limit, it can be seen that the detection limit of the HA detection signal after the second amplification is about 8 times smaller than the detection limit of the HA detection signal after the first amplification, which shows that the second amplification of the HA detection signal can achieve further sensitive detection of HA.

[0146] Through Figure 6 and Figure 8 The analysis of these two standard curves shows that Figure 6 The linear fitting degree of the standard curve in R 2 =0.982, Figure 8 The linear fitting degree of the standard curve in R 2 =0.991. The closer the value of the fitting degree is to 1, the better the fitting degree of the standard curve is. Figure 8 The better the standard curve fits, the more accurate the calculated HA concentration value will be.

[0147] By analyzing the data in Experiment 1 and Experiment 2, it can be seen that the present invention can detect HA with lower concentrations after amplifying the HA detection signal twice, and the detection limit is also reduced by 8 times, thereby improving its detection effect and achieving more sensitive detection of HA.

[0148] Example 3

[0149] Two groups of HA were selected with a concentration of 50 pg / mL, and the two groups of HA were subjected to Experiment 1 and Experiment 2 in Example 2 respectively. Fig.10 The experimental results.

[0150] Fig.10 The red curve in the middle is the DPV signal graph obtained by HA through Experiment 2; Fig.10 The black curve in the middle is the DPV signal diagram obtained by HA through Experiment 2. Fig.10It can be seen that the DPV current peak of the red curve is significantly greater than the DPV current peak of the black curve. The difference between Experiment 2 and Experiment 1 is that in Experiment 2, AuPtNFs amplification is achieved through the base complementary pairing principle of DNA. This can effectively prove that the amplification of AuPtNFs through the base complementary pairing principle of DNA can increase the detection signal of HA.

[0151] The above describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions only describe the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention. These changes and improvements fall within the scope of the present invention to be protected. The scope of protection claimed by the present invention is defined by the attached claims and their equivalents.

Claims

1. A method for detecting H1N1 influenza virus, characterized in that: It includes the following steps: Treating the sample HA to be tested: adding the sample HA to be tested to the MB-Au-Apt1 dispersion and mixing them completely to obtain a mixed solution 1; then separating the solid in the mixed solution 1 by an external magnetic field, and resuspending the separated solid in a PBS buffer; Then, the AuPtNFs-Apt2 dispersion was added to the PBS buffer solution for mixing to obtain a second mixed solution; the solid in the second mixed solution was separated by an external magnetic field to obtain MB-Au-Apt1@HA@AuPtNFs-Apt2, and the MB-Au-Apt1@HA@AuPtNFs-Apt2 was resuspended in a 1 / 4SSC buffer solution; the AuPtNFs-Probe dispersion was added to the 1 / 4SSC buffer solution for mixing to obtain a third mixed solution, the solid in the third mixed solution was separated by an external magnetic field, and the separated solid was resuspended in a PBS buffer solution to obtain a sample treatment solution; The prepared sample treatment solution is added dropwise onto the electrode of the electrochemical platform for detecting HA, and then the electrode is immersed in a PBS buffer containing HQ and H2O2 for a period of time; Then, DPV potential scanning was performed from −0.1 V to 0.6 V at a pulse amplitude of 50 mV, a pulse period of 500 ms, and a quiet time of 2 s; The electrochemical platform can obtain the concentration of HA of the sample to be detected through the result of potential scanning.

2. The method for detecting H1N1 influenza virus according to claim 1, characterized in that: In the process of treating the sample HA to be detected, the nucleic acid aptamer Apt1 in the MB-Au-Apt1 dispersion is used to capture HA and form a sandwich structure MB-Au-Apt1@HA@AuPtNFs-Apt2 with the nucleic acid aptamer Apt2 in the AuPtNFs-Apt2 dispersion.

3. The method for detecting H1N1 influenza virus according to claim 1, characterized in that: The AuPtNFs-Probe in the AuPtNFs-Probe dispersion is connected to the AuPtNFs-Apt2 on the MB-Au-Apt1@HA@AuPtNFs-Apt2 by base complementary pairing, thereby forming MB-Au-Apt1@HA@AuPtNFs-Apt2-AuPtNFs-Probe with multiple AuPtNFs-Probes.

4. The method for detecting H1N1 influenza virus according to claim 1, characterized in that: Before processing the sample HA to be detected, a nanocomposite material needs to be prepared. The nanocomposite material includes a MB-Au dispersion and an AuPtNFs dispersion.

5. The method for detecting H1N1 influenza virus according to claim 4, characterized in that: The preparation method of the MB-Au dispersion comprises the following steps: preparing Fe3O4 dispersion; The prepared Fe3O4 dispersion is dispersed in a mixture of ethanol and water, and ultrasonically dispersed, 25% ammonia water is added after ultrasonication, and tetraethyl orthosilicate is added dropwise, and then stirred at room temperature to obtain a suspension 1; The suspension is separated by a magnet, and washed with ethanol and deionized water for multiple times to obtain Fe3O4@SiO2; The prepared Fe3O4@SiO2 was dispersed in a mixture of ethanol and deionized water, and subjected to ultrasound. After ultrasound, 3-aminopropyltriethoxysilane was added dropwise, and stirred at room temperature for a period of time under nitrogen protection to obtain a second suspension. The suspension 2 is separated by a magnet, and washed with ethanol and deionized water for multiple times to obtain Fe3O4@SiO2-NH2, which is dispersed in 50 mL of deionized water to obtain MB dispersion; A certain amount of the MB dispersion is taken and subjected to ultrasonic treatment, and then HAuCl4 aqueous solution and sodium citrate aqueous solution are added respectively, and stirred, and after stirring for a period of time, sodium borohydride is added to react to obtain suspension three; The suspension three was separated by a magnet, and washed with ethanol and deionized water for multiple times to obtain MB-Au, which was then dispersed in 50 mL of deionized water to obtain the MB-Au dispersion.

6. The method for detecting H1N1 influenza virus according to claim 5, characterized in that: The preparation method of the AuPtNFs dispersion comprises the following steps: Adding the HAuCl4 solution into a container containing water to obtain a mixed solution 4, and heating the mixed solution 4 to boiling; Rapidly add sodium citrate solution to the boiling mixture 4 and boil while stirring. After boiling for a period of time, ascorbic acid and H2PtCl6 were added respectively, and heating was continued for 20 minutes to obtain the AuPtNFs dispersion.

7. The method for detecting H1N1 influenza virus according to claim 6, characterized in that: The preparation method of the MB-Au-Apt1 dispersion comprises the following steps: Taking a certain amount of the prepared MB-Au dispersion, adding the nucleic acid aptamer Apt1 to the MB-Au dispersion, and incubating at 25° C. for 2 hours to obtain a suspension IV; The supernatant of the suspension 4 is removed by a magnet to obtain a precipitate 1; the precipitate 1 is then washed with PBS buffer for three times; The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA, and shaken at 25° C. for 0.5 h to obtain a suspension solution 5; The suspension was separated by a magnet to obtain MB-Au-Apt1, and the MB-Au-Apt1 was resuspended in 200 μL of PBS solution to obtain the MB-Au-Apt1 dispersion.

8. The method for detecting H1N1 influenza virus according to claim 7, characterized in that: The preparation of the AuPtNFs-Apt2 also includes the following steps: Taking a certain amount of the prepared AuPtNFs dispersion, adding the nucleic acid aptamer Apt2 to the AuPtNFs dispersion, and incubating at 25° C. for 2 h to obtain a suspension VI; The supernatant of the suspension 6 is removed by a magnet to obtain a precipitate 2; the precipitate 2 is then washed with a PBS buffer solution for three times; The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA, and shaken at 25° C. for 0.5 h to obtain a suspension 7; The suspension was separated by a magnet to obtain AuPtNFs-Apt2, which was then resuspended in 200 μL of PBS solution to obtain the AuPtNFs-Apt2 dispersion.

9. The method for detecting H1N1 influenza virus according to claim 8, characterized in that: The preparation of the AuPtNFs-Probe dispersion also includes the following steps: Taking a certain amount of the prepared AuPtNFs dispersion, adding the DNA probe Probe to the AuPtNFs dispersion, and incubating at 25° C. for 2 hours to obtain a suspension eight; The supernatant of the suspension solution 8 is removed by a magnet to obtain a precipitate 3; and the precipitate 3 is washed with a PBS buffer solution; The washed precipitate was resuspended in 200 μL of PBS buffer containing 2% BSA, and shaken at 25° C. for 0.5 h to obtain suspension nine; The suspension was separated by a magnet to obtain AuPtNFs-Probe, which was then resuspended in 200 μL PBS solution to obtain the AuPtNFs-Probe dispersion.

10. The method for detecting H1N1 influenza virus according to claim 9, characterized in that: The DNA nucleotide sequence of the nucleic acid aptamer Apt1 is 5'-HS-(CH2)6-TACTGCACACGACACCGACTGTCACCATCACCTCGGCGCA-3'; And / or, the DNA nucleotide sequence of the nucleic acid aptamer Apt2 is 5'-HS-(CH2)6-GGCCTACCGTAGT GTGCGTGGGCACATGTTCGCGCCACCGTGCTACAAC-3'; And / or, the nucleotide sequence of the DNA probe Probe is 5'-HS-(CH2)6-GTTGTAGCACG-3'.

Citation Information

Patent Citations

  • Electrochemical sensor for adapters and method for detecting chlorpyrifos

    CN107367540A

  • Methylene blue-nanoflower, electrochemical aptamer biosensor system as well as preparation method and application thereof

    CN111537584A

  • H1N1 influenza virus detection method and kit thereof

    CN112067802A

  • Method for detecting food-borne enteropathogenic bacteria O157: H7 based on nucleic acid aptamers, nanoparticles and quantum dot markers

    CN113866408A

  • Preparation method of platinum nanoflower and application of platinum nanoflower in biogenic amine detection

    CN115673333A

Cited By

  • Multistage interface structure composite electrode for detecting ultramicro viruses in sewage as well as preparation method and application of multistage interface structure composite electrode

    CN122487466A